Prostate Cancer - Results from #24000

Navigating the PSA screening dilemma - Abstract January 22, 2013

Current controversies in the management of biochemical failure in prostate cancer - Abstract January 22, 2013

Case-control study of lifetime alcohol intake and prostate cancer risk - Abstract January 22, 2013

Overdiagnosis of prostate cancer - Abstract January 22, 2013

Trends in prostate cancer in the United States - Abstract January 22, 2013

Age and comorbid illness are associated with late rectal toxicity following dose-escalated radiation therapy for prostate cancer - Abstract January 22, 2013

Randomized, double-blinded, placebo-controlled, trial of risedronate for the prevention of bone mineral density loss in nonmetastatic prostate cancer patients receiving radiation therapy plus androgen deprivation therapy - Abstract January 22, 2013

Risk of prostate cancer among cancer survivors in The Netherlands - Abstract January 22, 2013

Coplanar intensity-modulated radiotherapy class solution for patients with prostate cancer with bilateral hip prostheses with and without nodal involvement - Abstract January 22, 2013

Development and clinical validation of a real-time PCR assay for PITX2 DNA methylation to predict prostate-specific antigen recurrence in prostate cancer patients following radical prostatectomy - Abstract January 22, 2013

Morbidity of focal therapy in the treatment of localized prostate cancer - Abstract January 21, 2013

Health-related quality of life in the Finnish trial of screening for prostate cancer - Abstract January 21, 2013

Ipilimumab in prostate cancer - Abstract January 21, 2013

SIU 2013 Congress website now open! January 21, 2013

Maximizing survival in metastatic castrate-resistant prostate cancer: A clinical viewpoint - Abstract January 19, 2013

Safety and efficacy of maintenance therapy with a nonspecific cytochrome P17 inhibitor (CYP17i) after response/stabilization to docetaxel in metastatic castration-resistant prostate cancer - Abstract January 18, 2013

Preoperative predictors of pathologic stage T2a and pathologic Gleason score ≤ 6 in men with clinical low-risk prostate cancer treated with radical prostatectomy: Reference for active surveillance - Abstract January 18, 2013

Opposing effects of androgen deprivation and targeted therapy on prostate cancer prevention - Abstract January 18, 2013

Current standards and future directions for prostate cancer radiation therapy - Abstract January 18, 2013

Screening for prostate cancer: An updated review - Abstract January 18, 2013

Page 1201 of 1435